Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Is Poised For A COVID-19 Recovery; Will Q2 Deliver?

13 Jul 2021

• By Jessica Merrill

Basketball rebound — Q2 could deliver a rebound for pharma manufacturers • Source: Alamy

Related Content

GSK Sees Light At End Of Shingrix Tunnel As COVID-19 Eases

28 Apr 2021

Novartis Big Earners Beat Q1 Forecasts

27 Apr 2021

Pandemic Perspectives: COVID-19 Upended Drug Launches In Ways That Will Stick

24 Mar 2021

GSK Has Big Ambitions In Vaccines, With An Eye On Blockbuster Opportunities

23 Jun 2021

The Extraordinary But Uncertain Growth Of The COVID-19 Market

26 May 2021

S&E Briefs: The Good and The Bad Of COVID-19 On Biotech's Top Line

06 May 2021

Credit Where It Is Due: Pfizer’s COVID-19 Vaccine Smashes Launch Records As Expected

04 May 2021

Related Companies

Johnson & Johnson

Novartis AG

Merck & Co., Inc.

GSK plc

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Regeneron Pharmaceuticals, Inc.

Eli Lilly and Company

Gilead Sciences, Inc.

Vir Biotechnology, Inc.

Additional Topics

Sales & Earnings Coronavirus COVID-19 Companies Commercial Business Strategies

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.